References
- Arni P., Mantel Th., Deparade E., Muller D. Intrasanguine host-mediated assay with Salmonella typhimurium. Mutation Research 1977; 45: 291–307
- Ashby J., Lefevre P. A., Burlinson B., Beije B. Potent mitogenic activity of 4-acetylaminofluorene to the rat liver. Mutation Research 1986; 172: 271–279
- Boeniger M. F., Stein H. P., Choudhary G., Neumeister C. E. Residual benzidine in imported and domestic benzidine dyes. Toxicology Letters 1981; 9: 415–420
- Bos R. P., Brouns R. M. E., VanDoorn R., Theuws J. L. G., Henderson Th P. The appearance of mutagens in urine of rats after the administration of benzidine and some other aromatic amines. Toxicology 1980; 16: 113–122
- Bos R. P., Brouns R. M. E., VanDoorn R., Theuws J. L. G., Henderson P. Involvement of non-oxidative enzymes in mutagenic activation of urine from rats, given benzidine and some other aromatic amines. Toxicology 1981; 21: 223–233
- Bos R. P., Van Doorn R., Yih-van der Hurk E., Van Gemert P. J. L., Henderson Th P. Comparison of the mutagenicities of 4-aminobiphenyl and benzidine in the Salmonella/microsome, Salmonella/hepatocyte and host-mediated assays. Mutation Research 1982; 93: 317–325
- Cerniglia C. E., Freeman J. P., Franklin W., Pack W. D. Metabolism of azo-dyes derived from benzidine, 3,3′-dimethylbenzidine and 3,3′-dimethoxybenzidine to potentially carcinogenic aromatic amines by intestinal bacteria. Carcinogenesis 1982; 3: 1255–1260
- Chipman J. K. Bile as a source of potential reactive metabolites. Toxicology 1982; 25: 99–111
- Chipman J. K., Millburn P., Brooks T. M. Mutagenicity and in vivo disposition of biliary metabolites of benzo(a)pyrene. Toxicology Letters 1983; 17: 233–240
- Connor T. H., Cantelli Forti G., Sitra P., Legator M. S. Bile as a source of mutagenic metabolites produced in vivo and detected by Salmonella typhimurium. Environmental Mutagenesis 1979; 1: 269–276
- DeFrance B. F., Carter M. H., Josephy P. D., Bryant D. W., Mc Calla D. R. Metabolism and mutagenesis of benzidine in Salmonella typhimurium strains TA98 and TA98 1,8-DNP6. Mutation Research 1985; 144: 159–163
- Garner R. C., Martin C. N., Clayson D. B. Carcinogenic aromatic amines and related compounds. Chemical Carcinogens, C. E. Searle. American Chemical Society. 1984; Vol. 1: 175–276
- Gorbach S. L. The intestinal microflora and its colon cancer connection. Infection 1982; 61: 379–384
- Hauser R., Matter B. E. Localization of E. coli K-12 in livers of mice used for an intrasanguineous host-mediated assay. Mutation Research 1977; 46: 45–48
- Hirom P. C., Millburn P., Smith R. L., Williams R. T. Molecular weight and chemical structure as factors in the biliary excretion of sulphonamides in the rat. Xenobiotica 1972; 2: 205–214
- IARC International Agency for Research on Cancer. Benzidine and its sulphate, hydrochloride and dihydrochloride. Monograph on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 1982; 29: 149–183
- Kerklaan P., Bouter S., Mohn G. Activation of nitrosamines and other carcinogens by mouse-liver S9, mouse hepatocytes and in the host-mediated assay produces different mutagenic responses in Salmonella TA1535. Mutation Research 1983; 110: 9–22
- Kerklaan P. R. M., Bouter S., Van Elburg P. A., Mohn G. R. Evaluation of the DNA-repair host-mediated assay. I. Induction of repairable DNA damage in E. coli cells recovered from liver, spleen, lungs, kidneys, and the blood stream of mice treated with methylating carcinogens. Mutation Research 1985; 148: 1–12
- Lazear E. J., Shaddock J. G., Barren P. R., Louie S. C. The mutagenicity of some of the proposed metabolites of Direct Black 38 and Pigment Yellow 12 in the Salmonella typhimurium assay system. Toxicology Letters 1979; 4: 519–526
- Lynn R. K., Garvie-Gould C. T., Milam D. F., Scott K. F., Eastman C. L., Ilias A. M., Rodgers R. M. Disposition of the aromatic amine, benzidine in the rat: characterization of mutagenic urinary and biliary metabolites. Toxicology and Applied Pharmacology 1984; 72: 1–14
- Maron D. M., Ames B. N. Revised methods for the Salmonella mutagenicity test. Mutation Research 1983; 113: 173–215
- Martin C. N., Kennelly J. C. Rat liver microsomal azoreductase activity in four azo dyes derived from benzidine, 3,3′-dimethylbenzidine or 3,3′-dimethoxybenzidine. Carcinogenesis 1981; 2: 307–312
- Martin C. N., Kennelly J. C. Metabolism, mutagenicity, and DNA binding of biphenyl-based azodyes. Drug Metabolism Reviews 1985; 16: 89–117
- Millburn P. Excretion of xenobiotic compounds in bile. The Hepatobiliary System, Fundamental and Pathological Mechanisms, W. Taylor. Plenum Press, New York 1976; 109–129
- Mohn G. R., Ellenberger J. Mammalian blood-mediated mutagenicity tests using a multipurpose strain of Escherichia coli K-12. Mutation Research 1973; 19: 257–260
- Moriya M., Ohta T., Sugiyama F., Miyazawa T., Shirasu Y. Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens. Journal of the National Cancer Institute 1979; 63: 977–982
- Morton K. C., Beland F. A., Evans F. E., Fullerton N. F., Kadlubar F. F. Metabolic activation of N-hydroxy-N,N'-diacetylbenzidine by hepatic sulphotransferase. Cancer Research 1980; 40: 751–757
- Morton K. C., King C. M., Baetcke K. P. Metabolism of benzidine to N-hydroxy-N,N'-diacetylbenzidine and subsequent nucleic acid binding and mutagenicity. Cancer Research 1979; 39: 3107–3113
- Morton K. C., Wang C. Y., Garner C. D., Shirai T. Carcinogenicity of benzidine, N,N′-diacetylbenzidine, and N-hydroxy-N,N′-diacetylbenzidine for female CD rats. Carcinogenesis 1981; 2: 747–752
- Neis J. M., vanGemert P. J. L., Roelofs H. M. J., Bos R. P., Henderson Th P. Mutagenicity of benzidine and 4-aminobiphenyl after metabolic activation with isolated hepatocytes and liver 9000 g supernatant from rat, hamster, and guinea pig. Mutation Research 1984; 129: 13–18